Iβve been in experimentation mode the past few days. Working on something new, which is fun and rather important for sustaining growth.
Innovation is the bridge to further expansion.
very cool π€―
thinking a bit about it
doing something like that now,
before its regulated and licensed to pharma,
but also while there no interest in enforcing the current Schedule 1 classifications,
is probably the best timing.